InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Håkan Englund, 董事. Director active across 1 company, notably Prostatype Genomics AB. In total, 2 reports have been published. History available since 4 June 2025. The latest transaction was filed on 29 July 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Håkan Englund is a board member of Prostatype Genomics AB. He plays a crucial role in the strategic direction of the company, participating in board meetings and contributing to important decision-making. Prostatype Genomics AB focuses on developing innovative solutions in the field of genomics, aiming to improve treatments for patients.